Robert Conley
Chief Research and Development Officer at atai Life Sciences
About
Robert Conley is Chief Research and Development Officer of AtaiBeckley, a role he took in 2025 after serving as Chief Scientific and Medical Officer at Beckley Psytech. His earlier industry roles include Senior Vice President at Eleusis and Chief Science Officer, Neuroscience at Eli Lilly and Co. He previously held academic positions at the University of Pittsburgh and the University of Maryland School of Medicine, where he remains an Adjunct Professor of Psychiatry and Psychopharmacology, and holds an MD from Maryland and a BA from Johns Hopkins University.
Invests in
BiotechMental Health
Colleagues at atai Life Sciences
Amir Kalali
Director at atai Life Sciences
Andrea Heslin Smiley
Director at atai Life Sciences
Anne Johnson
Chief Accounting Officer at atai Life Sciences
Christian Angermayer
Founder and Chairman of the Board at atai Life Sciences
Gerd Kochendoerfer
Chief Operating Officer at atai Life Sciences
Glenn Short
Chief Scientific Officer at atai Life Sciences
John Hoffman
Director at atai Life Sciences
Kevin Craig
Chief Medical Officer at atai Life Sciences